Candriam Eqs L Biotech R GBP Cap

add to virtual portfolio
This fund can be held in
Trading AccountISAJISASIPP

Fund Info

  • Yield History-
  • 3 Year sharpe0.65
  • 3 Year alpha-0.02
  • Distribution Typeaccumulation
  • BenchmarkNASDAQ Biotechnology TR USD
  • Legal StructureSICAV
  • Fund Size (month end)SICAV
  • OCF1.10%
  • IA SectorSpecialist
  • Manager GroupCandriam
  • DomicileLuxembourg
  • ISINLU1269736911

Investment Strategy

The objective of the sub-fund is to benefit from the performance of the market in global equities of companies in the biotechnology sector, on the basis of discretionary management.

Latest news

Currently there for this fund. Visit our news hub for other news .